UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046448
Receipt number R000053000
Scientific Title Heart Sound Analysis Using Machine Learning in patients with Aortic Valve Stenosis
Date of disclosure of the study information 2021/12/24
Last modified on 2025/01/13 12:56:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Heart Sound Analysis Using Machine Learning in patients with Aortic Valve Stenosis

Acronym

Heart Sound Analysis Using Machine Learning in patients with Aortic Valve Stenosis

Scientific Title

Heart Sound Analysis Using Machine Learning in patients with Aortic Valve Stenosis

Scientific Title:Acronym

Heart Sound Analysis Using Machine Learning in patients with Aortic Valve Stenosis

Region

Japan


Condition

Condition

Aortic stenosis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Diagnosis for severity of aortic stenosis by heart sound

Basic objectives2

Others

Basic objectives -Others

To build and algorithm for diagnosis of aortic stenosis severity using machine learning.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Relationship between the severity of AS estimated by deep learning and the severity of AS estimated by the Japanese Circulation Society Guidelines for the Treatment of Valvular Heart Disease, revised in 2020.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

<AS group>
(1) Those who are 20 years old or older at the time of obtaining consent
(2) Those who have been diagnosed with aortic valve stenosis
3) Those who will undergo echocardiography.
(3) Those who do not refuse to participate in this study.

<Non-AS group>
1) Those who are 20 years old or older at the time of obtaining consent.
(2) Patients who have a systolic murmur, but aortic stenosis has been ruled out.
(3) Patients who do not refuse to participate in this study.

<Control group>
(1) Patients aged 20 years or older at the time of obtaining consent
(2) Those who do not have a systolic murmur
(3) Patients who will undergo echocardiography
3) Those who do not refuse to participate in this study.

Key exclusion criteria

<Common to all three groups>
(1) Those who refuse to cooperate in the research after disclosing the information using the opt-out method.
(2) Others who are judged by the principal investigator to be inappropriate as research subjects.

Target sample size

1100


Research contact person

Name of lead principal investigator

1st name Toshiyuki
Middle name
Last name Nagai

Organization

Faculty of Medicine and Graduate School of Medicine, Hokkaido University

Division name

Department of Cardiovascular Medicine

Zip code

060-8638

Address

Kita-15 Nishi-7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan

TEL

011-706-6973

Email

nagai@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Yoshifumi
Middle name
Last name Miziguchi

Organization

Faculty of Medicine and Graduate School of Medicine, Hokkaido University

Division name

Department of Cardiovascular Medicine

Zip code

060-8638

Address

Kita-15 Nishi-7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan

TEL

011-706-6973

Homepage URL


Email

mizu-tay@med.hokudai.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Non profit foundation

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital

Address

Kita-14 Nishi-5, Kita-ku, Sapporo, Hokkaido 060-8638, Japan

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 09 Month 14 Day

Date of IRB

2021 Year 09 Month 14 Day

Anticipated trial start date

2021 Year 09 Month 14 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2021 Year 12 Month 23 Day

Last modified on

2025 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053000